A Unique Aseptic Filling Facility to Support the Life Science and Diagnostic Industries.
Pharmaceutical and Healthcare Packaging
Emballages en verre
Notre conditionnement primaire en verre est adapté à un usage pharmaceutique et médical.
Nos contenants en plastique
Nous fournissons tout un éventail de conteneurs conformes en plastique destinés aux solides et aux doses liquides.
Dispositifs de fermeture et distributeurs à l'épreuve des enfants
Découvrez nos dispositifs de fermeture résistants aux enfants, avec mise en évidence des altérations, ainsi que notre gamme de distributeurs innovants.
Nous fabriquons une bobine à usage pharmaceutique en 100% coton, pour prévenir l'humidité.
Nos implantations dans le monde entier
INCREASING SPEED TO MARKET
Stock holding facilities
Documentation & certification management
Import and export management
Reduced lead ties
- Unités de fabrication
- Bureaux commerciaux et pour l'innovation
Artificial Intelligence: Can it really help drug discovery?
Artificial Intelligence (AI) is making waves in many different industries around the world. However, many would argue that the most important development is seen in the medical sector. Machine learning is expected to make the hunt for new pharmaceuticals cheaper, faster, and a lot more effective. With that being said, continue reading to discover everything...
Origin Achieves ISO 13485 Certification for Best Practice in Medical Devices
As a leading UK pharmaceutical packaging company, we are pleased to announce we have been awarded ISO 13485 certification following an in-depth audit. The internationally agreed ISO standard is the main standard for medical devices and demonstrates to regulators our ongoing commitment to quality and best practice. ISO 13485 is a stringent standard...
Origin accepted into PHE National Microbiology Framework
Origin Ltd. is pleased to announce it has been accepted into the new national public health procurement scheme, designed to help grow capacity, push innovation and build resilience within the microbiology supply chain. Origin Healthcare Services will be included in the Framework Agreements under Public Health England’s National Microbiology Framework for Lot 1 (Diagnostics Goods and Services)...
R&D Activity Continues to Flourish in the Pharmaceutical Sector
With so much of the world being focused on the research and development activity on the vaccines for the omnipresent COVID-19 virus, it’s easy to overlook the parts of the biopharmaceutical industry and the progress it had made during 2020. 2020 was, for everyone, a tumultuous year, with a number of disruptions, but there were...
Building the UK’s domestic pharma manufacturing capability
The Coronavirus crisis brought into the spotlight shortcomings in the UK healthcare system and its supply chain – many of which the public would never have known about if it weren’t for these unprecedented times. Shortages in personal protective equipment at the start of the pandemic were the most widely covered in the media, but...